ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2020
Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.
Review in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 45 citations in OpenAlex.
- Article
- Temporal discrimination at the neck region is associated with severity of cervical dystonia.Scientific reports · 2025Article
- Chewing Dystonia and Sensory Modulation: An Exploratory Study of Intraoral Lidocaine Effects.Movement disorders clinical practice · 2025Article
- Unraveling a Decade of Misdiagnosis and Suffering: A Pioneering Diagnostic and Therapeutic Breakthrough in Resolving Chronic Oromandibular Dystonia After Years of Failed Multidisciplinary Approaches.The Journal of craniofacial surgery · 2025Article
- Dystonia: pathophysiology and the role of acupuncture in treatment.Wiener medizinische Wochenschrift (1946) · 2025Review
- Magnetic resonance-guided focused ultrasound in dystonia: a scoping review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Article
- Enhancing Motor Function and Quality of Life Combining Advanced Robotics and Biomechatronics in an Adult with Dystonic Spastic Tetraparesis: A Case Report.Biomimetics (Basel, Switzerland) · 2025Article
- The Role of Ultrasound in the Evaluation of Tardive Dyskinesia: A Case Series.Tremor and other hyperkinetic movements (New York, N.Y.) · 2025Article
- Review
- Review
- Review
- Role of Botulinum Toxin in Treatment of Secondary Dystonia: A Case Series and Overview of Literature.Toxins · 2024Review
- Health-Related Quality of Life in Romanian Patients with Dystonia: An Exploratory Study.Journal of clinical medicine · 2024Article
- GNB1 Encephalopathy: Clinical Case Report and Literature Review.Medicina (Kaunas, Lithuania) · 2024Review
- Spatiotemporal Gait Differences before and after Botulinum Toxin in People with Focal Dystonia: A Pilot Study.Movement disorders clinical practice · 2024Article
- Basis of movement control in dystonia and why botulinum toxin should influence it?Toxicon : official journal of the International Society on Toxinology · 2024Article
- Movement disorders in autoimmune encephalitis: an update.Journal of neurology · 2023Review
- Article
- Dystonias: Clinical Recognition and the Role of Additional Diagnostic Testing.Seminars in neurology · 2023Article
- GPi DBS treatment outcome in children with monogenic dystonia: a case series and review of the literature.Frontiers in neurology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Dystonia is a complex disorder with numerous presentations occurring in isolation or in combination with other neurologic symptoms. Its treatment has been significantly improved with the advent of botulinum toxin and deep brain stimulation in recent years, though additional investigation is needed to further refine these interventions. Medications are of critical importance in forms of dopa-responsive dystonia but can be beneficial in other forms of dystonia as well. Many different rehabilitative paradigms have been studied with variable benefit. There is growing interest in noninvasive stimulation as a potential treatment, but with limited long-term benefit shown to date, and additional research is needed. This article reviews existing evidence for treatments from each of these categories. To date, there are many examples of incomplete response to available treatments, and improved therapies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.